KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Shares Outstanding (Weighted Average) (2019 - 2025)

Historic Shares Outstanding (Weighted Average) for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $360.7 million.

  • GoodRx Holdings' Shares Outstanding (Weighted Average) fell 643.41% to $360.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $360.7 million, marking a year-over-year decrease of 643.41%. This contributed to the annual value of $385.7 million for FY2024, which is 599.0% down from last year.
  • Latest data reveals that GoodRx Holdings reported Shares Outstanding (Weighted Average) of $360.7 million as of Q3 2025, which was down 643.41% from $367.8 million recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Shares Outstanding (Weighted Average) registered a high of $413.4 million during Q3 2023, and its lowest value of $360.7 million during Q3 2025.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $396.9 million, with a median of $410.0 million in 2021.
  • As far as peak fluctuations go, GoodRx Holdings' Shares Outstanding (Weighted Average) soared by 4924.9% in 2021, and later tumbled by 674.44% in 2024.
  • GoodRx Holdings' Shares Outstanding (Weighted Average) (Quarter) stood at $410.0 million in 2021, then increased by 0.7% to $412.9 million in 2022, then fell by 0.62% to $410.3 million in 2023, then fell by 5.99% to $385.7 million in 2024, then decreased by 6.48% to $360.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $360.7 million for Q3 2025, versus $367.8 million for Q2 2025 and $379.2 million for Q1 2025.